Cargando…
Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus
Objectives Artificial intelligence (AI), including predictive analytics, has great potential to improve the care of common chronic conditions with high morbidity and mortality. However, there are still many challenges to achieving this vision. The goal of this project was to develop and apply metho...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2021
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294941/ https://www.ncbi.nlm.nih.gov/pubmed/33975376 http://dx.doi.org/10.1055/s-0041-1728757 |
_version_ | 1783725335676715008 |
---|---|
author | Tarumi, Shinji Takeuchi, Wataru Chalkidis, George Rodriguez-Loya, Salvador Kuwata, Junichi Flynn, Michael Turner, Kyle M. Sakaguchi, Farrant H. Weir, Charlene Kramer, Heidi Shields, David E. Warner, Phillip B. Kukhareva, Polina Ban, Hideyuki Kawamoto, Kensaku |
author_facet | Tarumi, Shinji Takeuchi, Wataru Chalkidis, George Rodriguez-Loya, Salvador Kuwata, Junichi Flynn, Michael Turner, Kyle M. Sakaguchi, Farrant H. Weir, Charlene Kramer, Heidi Shields, David E. Warner, Phillip B. Kukhareva, Polina Ban, Hideyuki Kawamoto, Kensaku |
author_sort | Tarumi, Shinji |
collection | PubMed |
description | Objectives Artificial intelligence (AI), including predictive analytics, has great potential to improve the care of common chronic conditions with high morbidity and mortality. However, there are still many challenges to achieving this vision. The goal of this project was to develop and apply methods for enhancing chronic disease care using AI. Methods Using a dataset of 27,904 patients with diabetes, an analytical method was developed and validated for generating a treatment pathway graph which consists of models that predict the likelihood of alternate treatment strategies achieving care goals. An AI-driven clinical decision support system (CDSS) integrated with the electronic health record (EHR) was developed by encapsulating the prediction models in an OpenCDS Web service module and delivering the model outputs through a SMART on FHIR (Substitutable Medical Applications and Reusable Technologies on Fast Healthcare Interoperability Resources) web-based dashboard. This CDSS enables clinicians and patients to review relevant patient parameters, select treatment goals, and review alternate treatment strategies based on prediction results. Results The proposed analytical method outperformed previous machine-learning algorithms on prediction accuracy. The CDSS was successfully integrated with the Epic EHR at the University of Utah. Conclusion A predictive analytics-based CDSS was developed and successfully integrated with the EHR through standards-based interoperability frameworks. The approach used could potentially be applied to many other chronic conditions to bring AI-driven CDSS to the point of care. |
format | Online Article Text |
id | pubmed-8294941 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Georg Thieme Verlag KG |
record_format | MEDLINE/PubMed |
spelling | pubmed-82949412021-07-23 Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus Tarumi, Shinji Takeuchi, Wataru Chalkidis, George Rodriguez-Loya, Salvador Kuwata, Junichi Flynn, Michael Turner, Kyle M. Sakaguchi, Farrant H. Weir, Charlene Kramer, Heidi Shields, David E. Warner, Phillip B. Kukhareva, Polina Ban, Hideyuki Kawamoto, Kensaku Methods Inf Med Objectives Artificial intelligence (AI), including predictive analytics, has great potential to improve the care of common chronic conditions with high morbidity and mortality. However, there are still many challenges to achieving this vision. The goal of this project was to develop and apply methods for enhancing chronic disease care using AI. Methods Using a dataset of 27,904 patients with diabetes, an analytical method was developed and validated for generating a treatment pathway graph which consists of models that predict the likelihood of alternate treatment strategies achieving care goals. An AI-driven clinical decision support system (CDSS) integrated with the electronic health record (EHR) was developed by encapsulating the prediction models in an OpenCDS Web service module and delivering the model outputs through a SMART on FHIR (Substitutable Medical Applications and Reusable Technologies on Fast Healthcare Interoperability Resources) web-based dashboard. This CDSS enables clinicians and patients to review relevant patient parameters, select treatment goals, and review alternate treatment strategies based on prediction results. Results The proposed analytical method outperformed previous machine-learning algorithms on prediction accuracy. The CDSS was successfully integrated with the Epic EHR at the University of Utah. Conclusion A predictive analytics-based CDSS was developed and successfully integrated with the EHR through standards-based interoperability frameworks. The approach used could potentially be applied to many other chronic conditions to bring AI-driven CDSS to the point of care. Georg Thieme Verlag KG 2021-06 2021-05-11 /pmc/articles/PMC8294941/ /pubmed/33975376 http://dx.doi.org/10.1055/s-0041-1728757 Text en The Author(s). This is an open access article published by Thieme under the terms of the Creative Commons Attribution-NonDerivative-NonCommercial License, permitting copying and reproduction so long as the original work is given appropriate credit. Contents may not be used for commercial purposes, or adapted, remixed, transformed or built upon. ( https://creativecommons.org/licenses/by-nc-nd/4.0/ ) https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited. |
spellingShingle | Tarumi, Shinji Takeuchi, Wataru Chalkidis, George Rodriguez-Loya, Salvador Kuwata, Junichi Flynn, Michael Turner, Kyle M. Sakaguchi, Farrant H. Weir, Charlene Kramer, Heidi Shields, David E. Warner, Phillip B. Kukhareva, Polina Ban, Hideyuki Kawamoto, Kensaku Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus |
title | Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus |
title_full | Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus |
title_fullStr | Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus |
title_full_unstemmed | Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus |
title_short | Leveraging Artificial Intelligence to Improve Chronic Disease Care: Methods and Application to Pharmacotherapy Decision Support for Type-2 Diabetes Mellitus |
title_sort | leveraging artificial intelligence to improve chronic disease care: methods and application to pharmacotherapy decision support for type-2 diabetes mellitus |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8294941/ https://www.ncbi.nlm.nih.gov/pubmed/33975376 http://dx.doi.org/10.1055/s-0041-1728757 |
work_keys_str_mv | AT tarumishinji leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT takeuchiwataru leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT chalkidisgeorge leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT rodriguezloyasalvador leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT kuwatajunichi leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT flynnmichael leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT turnerkylem leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT sakaguchifarranth leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT weircharlene leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT kramerheidi leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT shieldsdavide leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT warnerphillipb leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT kukharevapolina leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT banhideyuki leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus AT kawamotokensaku leveragingartificialintelligencetoimprovechronicdiseasecaremethodsandapplicationtopharmacotherapydecisionsupportfortype2diabetesmellitus |